prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |35 |36 |37 |38 |39 |40 |41 |42 |43 |44 |45 |46 |47 |48 |49 |50 |51 |52 |53 |54 |55 |56 |57 |58 |59 |review

hs-CRP and risk of future cardiovascular events in apparently healthy women

An important clinical consideration is the generalizability of these data, particularly to women.  In the Women's Health Study, a prospective cohort of some 38,000 middle-aged, predominantly postmenopausal American women who were free of cardiovascular disease at study entry, the relative risk of future vascular events increased as the level of C-reactive protein went from low-normal to high-normal.  This was true for all vascular events as well as for the specific combined endpoint of MI or stroke.

 

Reference:

Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-733.

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9727541&dopt=Abstract

 

Keywords:  C-reactive protein, Women's Health Study

Slide type:  graph